Skip to main content
FinSpry Logo
FinSpry
CGTX logo
CGTX
(NASDAQ)
Cognition Therapeutics, Inc.
$0.87-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cognition Therapeutics (CGTX) Stock Price & Financial Analysis

Cognition Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.82 - $0.88
52-Week High$3.83
52-Week Low$0.22
Open$0.86
Volume1.04M
Average Volume (3M)1.04M
Market Cap67.66M
Shares Outstanding77.95M
Price to Book (P/B)1.90
EV/EBITDA-1.10
50-Day MA$1.09
200-Day MA$1.33
52-Week Change127.34%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cognition Therapeutics

What is the current stock price for CGTX?

As of the latest trading session, CGTX stock trades at $0.87. The 52-week range is $0.22–$3.83, with a day range of $0.82–$0.88.

What is the P/E ratio for CGTX?

The P/E ratio (Price-to-Earnings) for CGTX is shown in the Key Statistics section. This valuation metric helps compare Cognition Therapeutics, Inc. to industry peers.

Does CGTX pay dividends?

Cognition Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGTX?

Based on 1 analyst, the consensus for CGTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CGTX?

Cognition Therapeutics's market capitalization is $67.7M, classifying it as a micro-cap company. Cognition Therapeutics operates in the Healthcare sector within the Biotechnology industry.